INTRODUCTION
The cystatins are a superfamily of cysteine protease inhibitors that are conserved throughout evolution. Early studies identified three families of the cystatin superfamily including the stefins, cystatins and kininogens [1] . The stefins (family 1 cystatins) are characterized as intracellular cysteine protease inhibitors of approx. 10 kDa that lack disulphide bonds. The cystatins (family 2 cystatins) are secreted proteins of 12-13 kDa that are found in most body fluids and contain disulphide bonds. The kininogens (family 3 cystatins) are secreted proteins of 68-120 kDa that are primarily found in blood and also have disulphide bonds. The primary structures of several of the cystatin genes and proteins have been described and several consensus regions identified. For example, the family 2 cystatin genes are characterized by their three-exon structure with conserved exon\intron splice sites and a clustering of some of these genes at the same genetic loci [2, 3] . Mutation analysis [4] and X-ray crystallography [5, 6] have revealed three conserved regions in the cystatin superfamily proteins that are considered to be important for the inhibition of cysteine proteases, including a glycine residue at the N-terminus, an active site sequence with conserved glutamine, valine and glycine residues, and a proline-tryptophan sequence.
Each family of the cystatin superfamily consists of multiple members ; cystatin family 2 contains the most members, including cystatins C, S, SN, SA [1] and, more recently, cystatins D, E\M and F [7] [8] [9] [10] . The tissue expression of the cystatins varies : some cystatins such as cystatin D exhibit a more restricted tissue distribution [7] , whereas others such as cystatin C are more Abbreviations used : Cres gene, cystatin-related epididymal spermatogenic gene ; 5h RACE, rapid amplification of 5h cDNA ends ; RT-PCR, reverse transcriptase-mediated PCR. 1 To whom correspondence should be addressed (e-mail Gail.Cornwall!ttmc.ttuhsc.edu).
The nucleotide sequence data reported will appear in DDBJ, EMBL and GenBank Nucleotide Sequence Databases under the accession numbers AF091503, AF090691, AF090692 and AF059244.
exon\intron splice junctions occur in identical locations as in the cystatin C gene. Furthermore, chromosomal mapping studies show that the Cres gene co-segregates with the cystatin C gene on mouse chromosome 2. Similar to the cystatin family 2 proteins, the Cres protein possesses the type A and B disulphide loops that are necessary for cystatin folding. Interestingly, Cres protein also possesses half of a type C disulphide loop. Although probably related to the cystatin genes, the Cres gene is distinct in that its promoter contains consensus motifs typical of regulated genes. Finally, reverse transcriptase-mediated PCR studies and the identification of new Cres cDNA clones indicate that the Cres mRNA is alternatively spliced, resulting in two Cres mRNAs that might be involved in the regulation of Cres function.
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broadly expressed [11] . Although it is well established by studies in itro that the cystatins are cysteine protease inhibitors with specificities against papain-like cysteine proteases such as cathepsins B, S, H and L, the functions of these proteins in i o are not well understood. However, roles in tumour invasion, inflammation and prohormone processing have been proposed [12] [13] [14] . Furthermore, several neurological diseases have been associated with mutations in specific cystatin genes, including familial epilepsy as a result of a mutated cystatin B gene [15] and amyloid angiopathy as a result of a single point mutation in the cystatin C gene [16] .
Several cystatin-like proteins have been identified that exhibit gene structure, amino acid sequences and\or expression patterns distinct from those of the classic cystatin proteins. These proteins include fetuin [17] , cystatin-related proteins [18] and, most recently, testatin [19] . The identification of these proteins has led to the premise that new cystatin families or subgroups of families exist that have evolved to perform tissue-specific functions distinct from the housekeeping-type functions of the classic cystatin proteins.
In previous studies by our laboratory the cystatin-related epididymal spermatogenic (Cres) gene was identified and shown to exhibit some sequence similarity with the cystatin family 2 of cysteine protease inhibitors [20] . Unlike the ubiquitous expression of the cystatin C gene, Cres gene and protein expression were restricted to a discrete population of germ cells in the testis and the proximal region of the caput epididymidis, suggesting implicit roles in reproduction [20, 21] . Recently, we have also determined that the Cres protein is expressed in the male and female anterior The deduced amino acid sequence is shown below the coding region of the exons. Numbering of nucleotides is based on the major transcription start site as j1 (large arrowhead) ; a weaker transcription start site at k15 bp is indicated by the small arrowhead. The full-length Cres cDNA starts at the major transcription start site. The initiator methionine codon is in exon 2 ; the first 19 residues represent a putative signal peptide with the signal peptide cleavage site indicated by the vertical arrow. The TATA-like element (CATAA) is boxed. The polyadenylation signal in exon 4 is underlined and a (TG) n repeat sequence in intron 1 is indicated by a dashed underline. (B) Schematic diagram of the Cres gene structure compared with the mouse cystatin C gene [2] . The Cres gene consists of four exons and three introns as indicated by the boxes and solid lines respectively. Exon 1 and part of exon 2 are a 5h untranslated sequence with several in-frame stop codons preceding the initiator methionine codon in optimal consensus in exon 2. A second methionine in good consensus is also present in exon 2 and a stop codon and polyadenylation signal are present in exon 4. Q, glutamine. The broken arrow indicates the major transcription start site. P1, P2, P6, oligonucleotide primers used for RT-PCR analysis of Cres mRNA. PAS1, PAS2, PAS3, oligonucleotide primers used in 5h RACE and primer extension studies.
MATERIALS AND METHODS

Animals and reagents
Mature male ICR strain mice were obtained from Harlan (Indianapolis, IN, U.S.A.). Mice were housed under a constant 12 h light\12 h dark cycle and were allowed free access to food and water. All animal studies were performed in accordance with the principles and procedures outined in the NIH Guidelines for Care and Use of Experimental Animals.
Oligonucleotides were commercially prepared by Gibco BRL (Gaithersburg, MD, U.S.A.). Radioisotopes were from New England Nuclear (Boston, MA, U.S.A.) and restriction endonucleases and DNA-modifying enzymes were from Gibco BRL.
Library screening
A C3HF\R1 male mouse lambda 2001 genomic library (kindly provided by C. Wright, Vanderbilt University) was screened for clones with the Cres gene by plaque hybridization with a radiolabelled mouse Cres cDNA [20] . The Cres cDNA was randomly primed with the use of [$#P]dCTP and the Prime-It II kit (Stratagene, La Jolla, CA, U.S.A.) and 8i10& c.p.m. of probe per ml of hybridization buffer [50 % formaldehyde\5iSSC\ 0.2 mg\ml salmon sperm DNA\0.4 mg\ml yeast RNA\50 µg\ml BSA\0.1 % SDS\12.5 mM sodium phosphate buffer (pH 6.6)] were incubated with the filters at 42 mC for 2 days. Filters were washed in 2iSSC\1 % (w\v) SDS at 42 mC and then at 65 mC before exposure to film. Phage DNA was isolated from the positive clones, subcloned into the Bluescript SKk vector (Stratagene) and sequenced.
Full-length mouse and rat Cres cDNA species were obtained by screening mouse testis and rat epididymal cDNA libraries in the UNIZAP vector (Stratagene) by using the original mouse Cres cDNA [20] and the hybridization and washing conditions described previously for genomic screening. Positive clones were excised in i o and the resulting phagemid was plated with Escherichia coli XL1Bl to prepare plasmid DNA for subsequent sequence analysis. The full-length human Cres cDNA was obtained by screening a human testis cDNA library in the ZAP Express vector (Stratagene) under low-stringency hybridization conditions and the $#P-labelled mouse Cres cDNA. In brief, filters were hybridized at 50 mC for 2 days in the presence of 5iSSC\0.1 % sodium pyrophosphate\50 mM sodium phosphate buffer (pH 6.6)\5iDenhardts\0.2 mg\ml salmon sperm DNA. Filters were washed in 2iSSC\0.1 % SDS at 50 mC and then at 65 mC before exposure to film.
Sequence analysis
Double-stranded sequence analysis was performed with α-$&S-dATP and the Sequenase 2 sequencing kit (Amersham, Cleveland, OH, U.S.A.). Automated sequencing was performed through the Texas Tech University Biotechnology Core facility under the direction of Dr. Susan San Francisco.
Genomic PCR and genomic walking
To obtain additional Cres genomic sequence, PCR was performed with the Elongase system (Gibco BRL) and mouse C3H genomic DNA obtained from the Jackson Laboratories (Bar Harbor, ME, U.S.A.). To obtain the remainder of intron 3 sequences not present in the original genomic clone, a forward primer was generated from intron 3 (5h-AGCACGCCCTGACGCCATTTC3h) and a reverse primer was generated from Cres cDNA (5h-GTGACAGACTTGAACCACAGGTT-3h) sequences. PCR was performed with 500 ng of DNA in the presence of each primer at 200 nM, each dNTP at 200 µM, 60 mM Tris\sulphate, pH 9.1, 18 mM (NH % ) # SO % , 1.6 mM MgSO % and 1 µl of Elongase enzyme mix. After an initial denaturation at 94 mC for 30 s, the PCR reaction was incubated at 94 mC for 30 s, 65 mC for 30 s and 68 mC for 7 min (35 cycles) followed by a single 68 mC 15 min incubation with a minicycler (MJ Research, Watertown, MA, U.S.A.). Genomic PCR with the Elongase system and Cres cDNA primers was also used to obtain intron 1 (forward, 5h-ACGAGGAAA-CCCAGAAGAACC-3h ; reverse, 5h-TGGCATGGAGTATCT-TGTCC-3h) and intron 2 (forward, 5h-CTTGCTATGCACAA-ACCCACTGAGACA-3h ; reverse, 5h-ACTGCGGGAGATCT-GAACATC-3h) sequences. PCR products were subcloned into the pGEM-T vector (Promega, Madison, WI, U.S.A.) and sequenced with SP6 and T7 primers.
To obtain Cres promoter sequence, the genomic walking method (Clontech, Palo Alto, CA, U.S.A.) was used. Nested anti-sense gene-specific primers generated from Cres exon 1 (5h-TTCTGTGACTCTCCCACCTGCTCGT-3h and 5h-TGGCCA-CCCCAGCCTTGTGGTTCTT-3h) were used with adaptor primers supplied by the manufacturer and Advantage Tth polymerase mix (Clontech) to hot-start PCR amplify mouse genomic fragments with ligated adaptor sequences. PCR was performed with an initial denaturation at 94 mC for 1 min to inactivate the TthStart antibody followed by 94 mC for 2 s, 72 mC for 3 min (6 cycles) and then 94 mC for 2 s, 67 mC for 3 min (31 cycles) followed by 67 mC for 4 min. The resulting PCR products were subcloned into the pGEM-T vector and sequenced with SP6 and T7 primers.
Primer extension and rapid amplification of 5h cDNA ends (5h RACE)
For primer extension studies, 30 µg of total RNA from the mouse proximal caput epididymidis were incubated with a $#P end-labelled Cres anti-sense primer (PAS1) (5h-TTCTGTGAC-TCTCCCACCTGCTCGT-3h) in the presence of 10 mM Tris\ HCl, pH 8.3, 90 mM KCl, 1 mM MnCl # , each dNTP at 200 µM and 0.25 unit\µl rTh reverse transcriptase (Perkin-Elmer, Foster City, CA, U.S.A.) at 70 mC for 1 h. cDNA products were analysed on an 8 % (w\v) polyacrylamide\6 M urea gel in TBE buffer.
Control reactions were performed in the absence of RNA. Endlabelling was performed by incubation of 10 pmol Cres primer in the presence of 50 mM Tris\HCl, pH 7.6, 10 mM MgCl # , 5 mM dithiothreitol, 100 µM spermidine, 30 µCi of [γ-$#P]dATP and 10 units of T4 polynucleotide kinase at 37 mC for 10 min, followed by 90 mC for 2 min to inactivate the enzyme. End-labelled products were purified by centrifugation through a G-25 Sephadex spin column (Boehringer Mannheim, Indianapolis, IN, U.S.A.) to remove free nucleotide.
5h RACE was performed with the 5h RACE system (Gibco BRL). Total RNA (1 µg) from the mouse proximal caput epididymidis was reverse-transcribed with a Cres anti-sense primer (PAS2) (5h-GTGACAGACTTGAACCACAGGTT-3h) and Superscript II reverse transcriptase (Gibco BRL) for 50 min at 42 mC. Reactions were incubated with RNAse mix (RNAse H and RNAse T1) for 30 min at 37 mC and then centrifuged through Glassmax spin columns. Purified cDNA species were dC-tailed and PCR amplified with the abridged anchor primer supplied by the manufacturer and a second nested Cres genespecific primer (PAS3) (5h-ACTGCGGGAGATCTGAACATC3h) in the presence of Taq DNA polymerase (Sigma Chemical Co., St. Louis, MO, U.S.A.). PCR was performed at 94 mC for 30 s, 55 mC for 30 s, 72 mC for 1 min (30 cycles). 5h RACE products were analysed by 1 % (w\v) agarose-gel electrophoresis in the presence of TAE buffer (1iTAE is 0.04 M Tris\0.001 M EDTA\0.11 % acetic acid) and then subcloned into the pGEM-T Easy vector (Promega) and sequenced.
Preparation of RNA
Total RNA was isolated from mouse tissues and LβT2 gonadotrope cells (a gift from P. Mellon) with the use of Trizol reagent (Gibco BRL) in accordance with the manufacturer's protocol.
Reverse transcriptase-mediated PCR (RT-PCR)
RT-PCR was performed with 1 µg of total RNA from mouse testis, epididymis and LβT2 cells, and 2 µg of RNA from mouse pituitary gland. RNA was incubated in reverse transcription reaction buffer containing 5 mM MgCl # , 50 mM KCl, 10 mM Tris\HCl, pH 8.3, 0.5 mM dNTPs, 20 units of RNAsin and 2.5 µM oligo(dT) for 30 min at 37 mC in the presence of 3 units of DNAse I (Boehringer Mannheim). After heat inactivation of the DNAse I at 75 mC for 5 min, 50 units of MuLV reverse transcriptase (Perkin-Elmer) was added and the reaction mixture was incubated at 42 mC for 15 min, followed by 99 mC for 5 min to inactivate the enzyme. An 18 µl portion of the 20 µl reverse transcription reaction was used for the PCR amplification of the Cres cDNA in the presence of 2 mM MgCl # , 10 mM Tris\HCl, pH 8.3, 50 mM KCl, 0.2 mM dNTPs, 0.5 µM forward and reverse Cres-specific primers and 1.25 units of Taq DNA polymerase (Sigma Chemical Co.). After an initial denaturation at 95 mC, PCR was performed at 94 mC for 1 min, 65 mC for 1 min (36 cycles) followed by 72 mC for 7 min with a minicycler (MJ Research). RT-PCR products were analysed by agarose-gel electrophoresis followed by staining with ethidium bromide. Oligonucleotide primers for PCR were designed from the mouse Cres cDNA : P1 (forward), 5h-GCAGGTGGAGAGTCACAG-AA-3h ; P2 (forward), 5h-CTGGCAGTTGGTGTGGATCA-3h ; P6 (reverse), 5h-GTGACAGACTTGAACCACAGGTT-3h.
Chromosomal mapping
Chromosomal mapping was performed with the assistance of the Jackson Laboratory (Bar Harbor, ME, U.S.A.). To identify restriction enzymes that would produce restriction fragment length polymorphisms, genomic DNA from C57BL6\J and M. spretus mice was digested with restriction enzymes BamHI, BglII, EcoRV, HindIII, MspI, PstI, P uII, SstI, TaqI and XbaI followed by Southern blot analysis. A 200 bp 5h Cres cDNA probe was prepared by random-primer labelling as described above. Mapping was performed by restriction digestion with MspI and Southern blot analysis on the 94 mice from the Jackson Laboratory interspecies backcross panel (C57BL6\JEiiSPRET\ Ei)F " iSPRET\Ei mice, known as the Jackson BSS panel [22] .
RESULTS AND DISCUSSION
Isolation and structural analysis of the Cres gene
Screening of a mouse genomic library with a random-primed Cres cDNA [20] identified clones containing Cres sequences. A sequence analysis of one clone showed that the genomic DNA fragment contained the complete exon 3 sequence flanked 5h and 3h by intron sequences. Two PCR strategies were then utilized to obtain the remainder of the Cres gene sequence and the Cres promoter and 5h flanking sequences. These studies show that the Cres gene is approx. 6.8 kb in size. A comparison of the genomic sequence with the mouse cDNA sequence revealed the presence of four exons and three introns ( Figure 1) . A computer-generated analysis (Splice Site Prediction by Neural Network) of the Cres exon\intron splice junctions showed these sites to be common donor\acceptor sequences observed in other genes. Exon 1 and part of exon 2 consist of 5h untranslated sequence with an initiator methionine codon in optimal context and a downstream methionine codon in good context [23] present in exon 2 ( Figure  1B ). On the basis of translational initiation at the first ATG there is a 19-residue signal peptide sequence with the cleavage site predicted to be between Ala"* and Val #! following established rules for predicting signal sequence cleavage sites [24] . A stop codon and polyadenylation signal are present in exon 4. A comparison of the Cres gene structure with the structure of family 2 cystatin genes revealed several similarities ( Figure 1B) . Although the Cres gene has an extra exon (exon 1), the remaining exons of the Cres gene containing the coding sequence are similar in size to that of the mouse cystatin C gene [2] . Furthermore, the exon\intron splicing occurs in the same location within the coding sequence of the two genes. For example, in the cystatin C gene, a splice site occurs within one of the consensus sites (Q\-V-G) in cystatin exon 1, which is thought to be critical for binding to cysteine proteases. Although the Cres sequence in this region is distinct, the splice site is identical with that of the cystatin C gene and occurs immediately after the glutamine residue in Cres exon 2 ( Figure 1B) . The possibility that splicing might occur before the glutamine residue cannot, however, be excluded because the same nucleotides (CAG) are at both the 5h and 3h termini of Cres intron 2 and the resulting mRNA would not differ if either splicing event occurred. Splicing before the glutamine residue, although possible, is unlikely because the splice junction would then be unconventional. The splicing of Cres exon 3 occurs 10 residues after a conserved cysteine residue and this splice site is in the same location within the coding region of the cystatin C gene, cystatin C exon 2 [2] . The sizes of the intron sequences, however, are quite different between the Cres and cystatin C genes. Unlike the relatively small size of the cystatin C introns [2] , the Cres gene has a large intron 2 with smaller introns 1 and 3. Another distinctive feature of the Cres gene is the presence of a (TG) "% -#! stretch in intron 1 ( Figure 1A ). This element is also present in the introns of the cystatin C gene [2] and in a cystatin-related protein gene [25] as well as in the promoters and\or introns of other genes not related to the
Figure 2 Determination of Cres transcription start sites by primer extension and 5h RACE assays
(A) Primer extension was performed with total RNA from the mouse proximal caput epididymidis and a 32 P end-labelled Cres anti-sense primer (PAS1) designed from the 5h region of the Cres cDNA (j). Control reactions were performed in the absence of RNA (k). The extended products were separated on an 8 % (w/v) polyacrylamide/6 M urea gel followed by exposure to film. Three primary extended products of 91, 72 and 64 bp were identified, with the 72 bp product being predominant. (B) 5h RACE was performed with total RNA from the mouse proximal caput epididymidis. RNA was reverse transcribed and the cDNA species were PCR amplified with two nested Cres anti-sense primers (PAS2, PAS3) followed by analysis of the 5h RACE products by agarose-gel electrophoresis and staining with ethidium bromide. A predominant PCR product of approx. 470 bp was observed. The PCR products were subcloned into the pGEM-T Easy vector and twelve clones were sequenced. (C) Schematic diagram of the Cres cDNA showing the location of the Cres anti-sense primer (PAS1) and extended products (horizontal arrows with thicker arrow indicating the predominant product) resulting from primer extension assays (top) and the location of the Cres anti-sense primers (PAS2, PAS3) and 5h RACE products (horizontal arrows with thicker arrow indicating the predominant product) generated from 5h RACE (bottom). The predominant primer extended product (72 bp) and most of the 5h RACE products placed transcriptional initiation at the adenine residue at the beginning of the full-length Cres cDNA. A weaker transcriptional start site was also identified 15 bp upstream of the major start site. The autoradiograms and photographs of the ethidium bromide stained gels were scanned with a Mirror 1200 colour scanner and the results were transferred into Adobe Photoshop 4.0.
cystatins, including the glutathione peroxidase-like [26] and CRISP-1 genes [27] . These elements have the potential to adopt alternative DNA conformations that might direct the binding of transcription factors or other regulatory proteins to sites in the promoter [28] .
Analysis of the Cres promoter
An examination of the Cres promoter revealed the presence of a TATA-like element (CATAA) approx. 25 bp upstream of the major predicted transcription start site ( Figure 1A) , which was confirmed by primer extension and 5h RACE assays. As shown in Figure 2 (A), primer extension with total RNA isolated from the mouse proximal caput epididymidis and an anti-sense primer (PAS1) designed from the 5h end of the Cres cDNA resulted in three extended products. The most abundant 72 bp extended
Figure 3 Analysis of the Cres promoter and 5h flanking sequences
The 1527 bp Cres 5h flanking sequences were examined for DNA-binding protein consensus sites with the computer program MATINSPECTOR [30] . The TATA-like element (CATAA) is indicated and the major transcription start site of exon 1 is shown by the large arrowhead (j1) ; the weaker transcription start site is indicated by the small arrowhead. The consensus motifs for cis-elements characterized in other gene promoter and enhancer sequences are boxed. Abbreviations : GATA, GATA-binding factor 1 ; Ptx1, pituitary homeobox 1 ; Sry, sex-determining region Y gene product ; GRE, glucocorticoid response element ; ARE, androgen response element ; Sox5, Sry-related high mobility group (HMG) box ; AP-1, activator protein 1 ; C/EBP, CCAAT/enhancer-binding protein ; CREB, cAMP-response-element-binding protein ; ERE, oestrogen response element ; SF-1, steroidogenic factor 1.
product predicted the major transcription start site to be at or near the beginning of the mouse full-length cDNA ( Figure 2C ; Figure 1A , large arrowhead). The longer and less abundant product of 91 bp predicts a weaker transcription start approx. 15 bp further upstream ( Figure 2C ; Figure 1A , small arrowhead). The shorter, less abundant product (64 bp) probably represents premature stalling of the reverse transcriptase enzyme. The transcription start sites predicted by primer extension assays were confirmed by 5h RACE. 5h RACE with nested Cres antisense primers (PAS2 and PAS3) ( Figure 2C ) resulted in a predominant PCR product of the expected size on the basis that the transcription start was at the beginning of the full-length Cres cDNA ( Figure 2B ). Sequence analysis of the cloned PCR products showed that most of the PCR products terminated at the major transcription start site predicted by the primer extension assays. This placed transcriptional initiation at an adenine residue, which is typical of most eukaryotic genes [29] ( Figure  1A , large arrowhead). One of the PCR products, however, represented an mRNA initiated from an adenine residue at the weaker transcription start site approx. 15 bp upstream of the major start site.
An examination of the Cres promoter and 5h flanking sequences with a computer program to predict consensus DNA\protein-binding sites [30] revealed the presence of putative binding sites for transcription factors known to interact with the promoters of regulated genes (Figure 3 ). There were several DNA motifs characteristic of genes involved in steroidogenesis and reproductive function, including three oestrogen response elements Figure 4 Alternative splicing of the Cres mRNA (A) Ethidium bromide-stained agarose gel of the RT-PCR products generated from mouse caput epididymal RNA (EPI) with the P1/P6 and P2/P6 primers. RT-PCR with the P1/P6 primers resulted in two PCR products of 630 and 480 bp, whereas RT-PCR with the P2/P6 primers resulted in a single PCR product of 450 bp. (B) Ethidium bromide-stained agarose gel of RT-PCR products generated from mouse caput epididymis (EPI), testis (TE), LβT2 gonadotrope cell line and pituitary (PIT) RNA with the P1/P6 primers. In all tissues the predominant RT-PCR product was the larger 630 bp product. Photographs of the ethidium bromide-stained gels were scanned with a Mirror 1200 colour scanner and the data were transferred into Adobe Photoshop 4.0.
[31] near the Cres transcription start site (k41, k59 and k106 bp) as well as an androgen response element\ glucocorticoid response element [32] half site at k1229 bp. A single steroidogenic factor 1 [33] site with 100 % conservation was also present at k60 bp as well as a Pit-1 [34] site at Figure 5 Comparison of Cres and cystatin C cDNA and amino acid sequences (A) Nucleotide sequence of the full-length mouse, rat and human Cres cDNA species. The 5h untranslated, full coding and 3h untranslated sequences are shown. The initiator and downstream methionine codon and the stop codon are boxed. The polyadenylation signal is underlined. The sequence between the arrows is missing from the mouse splice variant cDNA. The overall nucleotide sequence similarity in the coding region between the mouse and rat Cres cDNA species is 91 % and between mouse and human is 73 %. (B) Derived amino acid sequences for the mouse, rat and human Cres proteins compared with the human cystatin C protein. The three consensus motifs considered necessary for cystatin function are boxed. Cysteine residues are in white on a black background. The derived amino acid sequence similarity between mouse and rat Cres protein is 83 % and between mouse and human Cres protein is 58 %. The sequence similarity between human Cres and cystatin C proteins is 27 %. Broken lines represent gaps introduced for alignment.
k1469 bp and four pituitary homeobox 1 [35] sites at positions k398, k756, k802 and k1469. In addition, seven consensus sites that bind the sex-determining region Y transcription factor [36] and its related DNA-binding protein Sox-5 [37] were present throughout the 1.6 kb of Cres promoter sequences. Other DNAbinding sites in the Cres promoter included those for CCAAT\ enhancer-binding protein [38] , cAMP-response-element-binding protein [39] and GATA-1-binding protein [40] . Considering the highly restricted expression of the Cres gene to the testicular haploid germ cells, epididymis [20] and the anterior pituitary gonadotropes (G. Sutton and G. A. Cornwall, unpublished work), the presence of some of these DNA-binding elements is not surprising and might suggest a means by which the Cres gene is regulated. However, whether these sites are functional remains to be determined. Studies are currently in progress to assess these DNA elements in Cres gene regulation.
Alternative splicing of the Cres mRNA
During the course of using RT-PCR to examine Cres gene expression in mouse tissues, it was observed that one set of primer pairs (P1, P6) designed from the original Cres cDNA resulted in two PCR products, whereas another primer pair (P2, P6) resulted in a single PCR product from the same mouse caput epididymal RNA sample ( Figure 4A ). This was shown not to represent a priming artifact of the primers from the mRNA because PCR of the cDNA with the (P1, P6) primer pair resulted in a single PCR product of the expected size (results not shown). To determine whether the PCR products represented different Cres mRNA species, the PCR products were cloned and sequenced. The larger PCR product contained an additional 143 bp sequence not present in the smaller PCR product. A comparison of the PCR sequences with the Cres genomic sequence revealed that the 5h half of exon 2 was present neither in the smaller PCR product nor in the original cDNA sequence ( Figure 1B) . Additional library screening of mouse testis, rat epididymal and human testis cDNA libraries identified Cres cDNA species of 692, 707 and 877 bp respectively, all of which when sequenced contained the 143 bp 5h half of exon 2 and therefore seemed to represent the full-length and correctly spliced Cres mRNA species (Figures 5A and 5B ). An examination of the sequence surrounding the alternative splice site in the middle of exon 2 showed a consensus intron\exon splice junction with a predicted splicing score (0.78) slightly less than the splicing score for the correct intron 1\exon 2 splice junction (0.87). Therefore, because the 5h region of exon 2 is a conserved intron\exon splice sequence, both splice sites are utilized in the processing of the Cres mRNA and two Cres mRNAs are produced. However, an analysis of the relative proportions of the two Cres mRNA species in tissues that express the Cres gene revealed that most of the Cres mRNA was spliced at the first splice site and thus the splice variant mRNA was a minor form ( Figure 4B) .
The functional significance of the alternative splicing of the Cres mRNA has yet to be determined. Because the splice variant mRNA lacks the 5h half of exon 2 it lacks the initiator methionine codon and therefore if translated would utilize a downstream ATG codon in exon 2. The resulting truncated protein would be approx. 12 kDa and would lack the signal sequence as well as additional amino acids present in the mature Cres protein.
Preliminary transcription and translation studies in itro indicate that translational initiation can occur at the second ATG in the Cres sequence (results not shown). Therefore the utilization of different ATG codons might be a means of regulating Cres protein function. Interestingly, alternative splicing of the cathepsin B mRNA also results in deletion of the signal peptide sequence with subsequently a unique intracellular localization of the protein [41] .
Chromosomal mapping of the Cres gene
To determine the chromosomal localization of the Cres gene, genetic mapping studies were performed. Southern blot analysis of DNA from 94 backcrosses derived from the matings of (C57BL6\EiiSPRET\Ei)F " iSPRET\Ei mice was performed by using the mouse Cres cDNA. The allele pattern of Cres was compared with approx. 4000 other loci previously mapped in the Jackson BSS cross and linkage was found to the distal region of chromosome 2 ( Figures 6A and 6B) . The Mouse Nomenclature Committee of the Jackson Laboratory (Bar Harbor, ME, U.S.A.) has approved this locus Cres (MGD accession number J : 48910). The mapping studies also showed that the Cres gene cosegregated with the cystatin C (Cst 3) locus. The mapping of the Cres and cystatin C genes to the same genetic loci is not surprising because the Cres gene seems to be evolutionarily related to the cystatin family 2 members. Several of the cystatin family 2 genes, including cystatins C, D, S, SN and SA [3] , have been shown to cluster on human chromosome 20, which exhibits a region of linkage conservation with the distal region of mouse chromosome 2.
Evolutionary relationship of Cres to the cystatin superfamily
The similarity of the Cres genomic structure and splice junctions with the cystatin C gene as well as the co-segregation of Cres with cystatin C on mouse chromosome 2 indicate that the Cres gene is most probably derived from the same ancestral gene as the cystatin C gene. A phylogenetic tree constructed with the MegAlign program of the Lasergene Software Suite (DNA STAR, Madison, WI, U.S.A.) formally demonstrates the evolutionary relationship between the mature protein sequences of Cres and the cystatin families ( Figure 7) . The alignment suggests that Cres protein, although probably a new member of the family 2 cystatins, is distinct from the cystatins C, D and S and might therefore represent a new subgroup within the family. Cres protein, like the family 2 cystatins, contains the prolinetryptophan (PW) residues thought to participate in the interaction of cystatins with cysteine proteases ( Figure 5B ). Although the Cres sequence also contains the glutamine (Q) residue at the appropriate site of a second consensus motif for
Figure 7 Evolutionary relationship of the Cres protein to the cystatin superfamily
The phylogenetic tree was generated with the MegAlign program of the Lasergene Software Suite (DNA STAR). Signal sequences were removed before alignment. Only the cystatin domains in the kininogens were used in the alignment. The construction of the tree utilized the clustal method with the PAM 250 alignment matrix. The multiple alignment parameters were : gap penalty, 20 ; gap length penalty, 20. The pairwise alignment parameters were : ktuple, 1 ; gap penalty, 3. inhibition (Q-V-G), the other residues are quite unique from that in the cystatin C sequence. Finally, whereas mouse and rat Cres sequences possess a glycine residue in an appropriate position at the N-terminus to form a third consensus motif for cystatin function, the human Cres sequence does not ( Figure 5B ). Cres protein is also like the mammalian single domain cystatin proteins in that it contains both the type A and B disulphide loops with the appropriate spacing between the cysteine residues. In all three species the Cres sequence also possesses a third cysteine residue in the N-terminus, suggesting that Cres might contain half of a characteristic type C disulphide loop that is present in insect cystatins as well as in a cystatin domain of the three cystatin domain proteins fetuin and kininogen.
Taken together, these studies suggest that the Cres gene represents a new subgroup within the family 2 cystatins. However, unlike the proposed function of the cystatins as general regulators of cysteine protease activities, the highly regulated and tissuespecific expression of the Cres gene implies that it might perform very specific functions in the reproductive tract. On the basis of our previous studies that Cres protein is present in the luminal fluid of the proximal caput epididymidis [20] as well as our recent observations that Cres protein co-localizes with LHβ protein to the anterior pituitary gonadotrope secretory granules (G. Sutton and G. A. Cornwall, unpublished work) as well as to the sperm acrosomes, a lysosome-like structure (P. Syntin and G. A. Cornwall, unpublished work), suggests that Cres protein might have roles in the regulation of prohormone and sperm acrosomal and plasma membrane protein processing. Furthermore, our finding that there is an alternatively spliced Cres mRNA lacking the signal sequence suggests that Cres protein might function intracellularly as well as extracellularly.
